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ABStRACt
Introduction: Approximately 3% of malignant tumors originate in the oral cavity. The majority are squamous cell 
carcinomas, and a small percentage, malignant tumors of the salivary glands, lymphoreticular diseases, bone tumors, 
melanomas, sarcomas, malignant odontogenic tumors and metastases of tumors from other locations. The prognosis of 
these pathologies depends on the size, infiltration, and site of the lesion, the presence or absence of metastatic spread, 
and to a certain degree the differentiation of the tumor. The prognosis of an oral cancer remains generally negative, with 
5-year survival figures below 50%, producing high rates of mortality and morbidity. 
Objectives: To evaluate the influence of different variables on survival in an oral cancer population. 
Patients and methods: Two-hundred and sixteen patients with oral squamous cell carcinoma were studied over a period 
of five years, evaluating 42 variables grouped into five data sections: personal, lesion, site, stage, and risk factors. 
Results and conclusions: Average survival was 2088 days, with a standard deviation of 98 days. The factors most as-
sociated with mortality were: location in the gingiva (p=0.0590), in the trigone (p=0.0104), size (T3-T4) (p=0.0004) and 
lymph node involvement (N2a-N2b) (p=0.0035). Tobacco and alcohol, nowadays considered to be highly significant in 
carcinogenesis, had no considerable influence on survival. 
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INtROduCtION
Cancer is a multifactorial disease, brought on by a combina-
tion of causal and predisposing factors, and which at a given 
moment and under favourable conditions may take effect in 
predisposed persons. Mortality from malignant neoplasms 
figures amongst the principal causes of death worldwide, 
and is therefore a highly serious public health problem. 
The primary incidences of cancers among men are of the 
prostate, lung and bronchus, and colon and rectum; and in 
women particularly breast, lung and bronchus, colon and 
rectum (4). Approximately 3% of malignant tumors origi-
nate in the oral cavity. The majority correspond to squamous 
cell carcinomas, and a small percentage to malignant tumors 
of the salivary glands, lymphoreticular disease, bone tumors, 
melanomas, sarcomas, malignant odontogenic tumors and 
oral metastases of tumors from other locations. The prog-
nosis of these pathologies depends on the size, infiltration 
and site of the lesion, presence or absence of metastasis 
and to a certain degree the differentiation of the tumor (1). 
Oral cancer still has a generally negative prognosis, with 
five-year survival figures of less than 50%, producing high 
rates of mortality and morbidity (2, 3). There is a wide vari-
ation in the incidence and mortality rates of oral cancer in 
the different regions throughout the world. The incidence 
of oropharyngeal and oral cancer in men is greater in the 
Lower Rhine area of France; in the south of India, where 
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it is the most frequent form of cancer, in certain areas of 
central and eastern Europe, and in some regions of Latin 
America (5, 6). In females the highest incidence is found in 
India, with a moderate increase in mortality in Central and 
Eastern Europe observed during the eighties and nineties 
(7). Cohort studies demonstrate that the incidence of oral 
cancer has increased in all ethnic groups worldwide in recent 
decades (6), especially in young men in Eastern Europe 
(7, 8). The increased risk has been noted in 19 out of 24 
European countries, finding an increase of 3 to 10 times 
within a single generation (9, 10); however, a tendency for 
the incidence of oral cancer to reduce in certain countries 
of Latin America and the Caribbean has been observed 
(5). Thus, oral cancer is a not very frequent disease, with an 
incidence that varies according to the geographic area, these 
epidemiological differences being largely attributable to the 
different customs prevailing in each region, above all with 
respect to the prevalence of known risk factors. 
When reviewing the literature, we can see how different 
factors have been evaluated as prognostic markers in oral 
cancer. Leite et al. (11) studied various parameters, high-
lighting clinical stage, gender, early diagnosis, treatment 
modality and the time elapsed between initial symptoms 
and treatment as principal prognostic factors. Beltrami et 
al. (12), studied the prognostic influence of factors such as 
tumor site, size, microscopic grade and DNA content. Other 
authors, such as González et al. (13), evaluated clinical and 
histopathological parameters in relation to survival, the 
most influential factors being location, size, lymph node 
metastasis, clinical stage, degree of cellular differentiation 
and pleomorphism. 
In a study carried out at the Canniesburn Hospital, Glasgow 
in 2000, the authors concluded that despite the advances 
in diagnosis and adjuvant treatment, no improvement in 
survival has been seen in the last 16 years, referring to a 
five-year survival rate of 44% (14, 15). 
Given that few studies have been carried out on prognostic 
indicators for survival in oral cancer, and that in many of 
these studies a multivariate analysis was not used to justify 
the results, the objective of our study is to evaluate the in-
fluence of different variables on survival in an oral cancer 
population. 
PAtIeNtS ANd MethOdS
The study population comprised all patients diagnosed 
with oral squamous cell carcinoma at the Oral and Maxil-
lofacial Surgery Unit, Granada, between January 1994 
and May 1999. The clinical records were compiled at the 
Maxillofacial Surgery Unit, from the surgical archives of 
the Traumatology Hospital, the Central Archive of  the 
University Hospital, Virgen de las Nieves, and the database 
of the NHI (National Health Institute). 
It was possible to select and review 253 case histories: 37 
were rejected for having an incomplete clinical history, lack 
of data regarding diagnostic tests, for incomplete data on 
clinical course and evolution, transfer to another hospital, 
or for lack of continuity in follow-up. The sample therefore 
reduced to 216. 
Patients were aged between 21 and 96 years, with the median 
situated in the 60-70 decade. The minimum age was 21 and 
the maximum 96, giving a range of 75 years; however the 
next highest age above 21 was 29, which would indicate that 
the first case was exceptional. With regard to gender, 75.9% 
were male and 24.1% female. 
The variables included in the study were: origin (rural/
urban), province (Almeria, Granada, Jaen), gender, age, 
presence of neoplastic lesions, tumor site, size, lymph node 
involvement, smoking, consumption of alcohol, periodontal 
disease, prosthetic trauma, trauma caused by sharp teeth 
and edentulism. 
The study design was observational, analytical and retro-
spective. The data sheet for data collection in the study group 
contained 42 variables, grouped into five sections: personal 
data, lesions, location, preoperative stage or characteristics 
of the tumor, and risk factors. 
Survival for each variable was analyzed using the Kaplan 
Meier method, and comparison between variables made 
using the Breslow test. Finally the multivariate analysis to 
obtain independent predictors of mortality was made using 
Cox proportional hazards models. Construction of the final 
model containing those variables found to be independently 
associated with survival in oral cancer was made in three 
stages: in the first, adjustments were made for each variable 
separately plus those that were clearly significant, then a new 
model was adjusted in which the combined effect of these 
variables was measured (Model I). From this model, those 
variables that could be eliminated without loss of informa-
tion were determined; thus creating the definitive model, 
which we called Model II.
ReSultS 
Data relating to death were compiled through the NHI. 
Of the 216 patients, the current situation is known for 188, 
while certain information for the remainder was lacking 
and could therefore not be used. Of the 188 patients, 44 
died from the disease. 
From the survival distribution (Figure 1), we calculated the 
possible parameters, thus the mean survival was 2088 days 
with a standard deviation of 98 days; the median could 
not be calculated since of the 188 patients, only 44 died 
corresponding to 23.4% of deceased patients and not the 
50% required to calculate the median. In any case, the 25 
percentile was 915 days with a standard deviation of 2111 
days, indicating that 75% of  patients survived for more 
than 915 days. 
After carrying out a bivariate correlation for the survival 
curves of the different factors studied, the most relevant 
factors are as follows: Regarding province, there were no sig-
nificant differences (X2exp= 2.08, 2g.1., p= 0.273), however, 
the curve for Almeria did seem somewhat better, although 
without reaching significance. On examining gender, there 
were indications that men with oral cancer tend to survive 
for shorter periods than women (X2exp= 3.73, 1g.1., p= 
0.0535) (Figure 2). There are indications that patients with 
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previous neoplastic lesions tend to survive longer than those 
without, (X2exp= 3.54, 1g.1., p= 0.0599) (Figure 3). With 
respect to site, the results were as follows: discreet, almost 
significant differences among those were the lesion presented 
in the gingiva, who appear to have shorter survival (X2exp= 
3.57, 1g.1., p= 0.0590) (Figure 4). Patients with a lesion in 
the labial commissures also tend to have shorter survival 
(X2exp= 3.71, 1g.1., p= 0.0542); however, it must be taken 
into account that the sample size was small, 5 out of 188, 
and this result should be taken with caution (Figure 5). 
Patients with lesions in the retromolar trigone also showed 
a reduced survival (X2exp= 6.57, 1.g1., p= 0.0104). The 
average survival in the 165 patients without a lesion in this 
area was 2184 days, against 926 days for the 27 patients who 
did have a lesion in the trigone (Figure 6). On the tongue, 
101 lesions were found, 7 in the ventral tongue, none on the 
dorsal tongue, 10 on the anterior left lateral tongue, 16 on 
the mid left lateral tongue, 13 on the posterior left tongue, 
4 on the anterior right lateral tongue, 22 on the mid right 
lateral tongue, 5 on the posterior third right lateral tongue, 
16 on the left base of the tongue, and 8 on the right base of 
the tongue. There were no significant differences between 
the survival curves for the different tongue sites (X2exp= 
6.9, 1.g1., p= 0.4064). 
Regarding tumor characteristics, this information was lost 
in some patients, finding that 61 patients who presented the 
tumor in stages T3-T4 had a lower survival than the 124 in 
stages T1-T2. While the mean survival in the first group was 
1576 days, in the second this was 2265 days (X2exp= 12.66, 
1g.1., p= 0.0004) (Figure 7). Those patients with tumors in 
stages N2a-N2b, had a lower survival than those who were 
in stages N0-N1 (X2exp= 8.51, 1g.1., p= 0.0035) (Figure 
8). With respect to smoking, no significant differences were 
found between the survival curves for this variable (X2exp= 
1.96, 1g.1., p= 0.1620). This could be due to the strong im-
balance between the sample sizes: while 144 were smokers, 
only 48 when non-smokers (Figure 9). Although there are no 
significant differences, (X2exp= 2.47, 2.g.1., p= 0.1933), it 
would seem clear that those patients with slight periodontal 
disease lived on average longer than those with serious peri-
odontal disease or edentulous patients (Figure 10). 
The remainder of the variables studied presented no signifi-
cant differences between their survival curves.
The multivariate analysis (Table 1) was made using those 
variables found to be significant in the bivariate analysis, 
thus determining the influence on survival of each variable 
independently, since for model 0, the results obtained may 
have been due to a certain influence of some variables on 
others. 
From the multivariate analysis Model I was obtained in 
which it could be observed that the majority of the variables 
reduced in significance; in addition in the case of the com-
missure, tobacco and alcohol had clearly lost significance, 
thus a new model was tried in which these variables were 
eliminated, observing that no information was lost, thus 
leaving us with Model II as the definitive. From this model 
we can conclude that presenting a lesion in the gingiva in-
creases risk of death by 1.72 times than when it does not, 
and that the presence of a lesion in the trigone increases 
the risk of death by 2.14 times than were the lesion not at 
this site. Patients with tumors of size T3-T4 present a risk 
of death 1.89 times greater than those with tumors in lower 
stages. Patients whose tumor was in stage N2a-N2b had a 
risk of death of 1.60 times higher than those with tumors 
in lower stages. 
dISCuSSION
In the results section, we observed mean survival figures of 
2088 days, and more than 915 days for 75% of patients, other 
studies offer figures of 43% at five years, Mohit-Tabatabay et 
al. (16) and Al-Kourainy (17), we can also observe in Table 1 
how risk of death from oral cancer is increased by 1.7 times 
more in smokers than in non-smokers, a small percentage 
by any standards, given the importance attributed to this 
risk factor in the majority of studies. We should take into 
account that the disproportion between the sample sizes 
does not allow us to extract net conclusions with respect to 
the role played by tobacco. 
With regard to survival from oral cancer between rural and 
urban populations, it can be seen from the group of cases 
that patients from rural areas have lower survival with 
respect to those from urban areas, a possible hypothesis 
being a worse access to diagnosis and treatment, likewise 
the possibly lower sociocultural level, continued exposure 
to the sun and dietary habits. 
Different opinions exist in the literature with regard to 
gender as a possible prognostic factor. Pugliano et al. (18) 
speak of a greater survival in women; however Shah et al. 
(19) believe that survival in females is lower. Other authors 
find no significant differences between the sexes. In our 
study, we can see indications that males tend to survive less, 
however without being clearly significant. 
It is important to determine the influence the site of the 
primary tumor has on the prognosis for the patient. Among 
the reasons given in explanation of this difference in prog-
nosis are found ease of early diagnosis, accessibility or ease 
for extirpation of the tumor with sufficient surgical margin, 
and the different lymphopathy that each site presents, and 
which manifests in its greater metastatic capacity.
Our study indicates that the location of  oral squamous 
cell carcinoma in the gingiva and in the trigone carries the 
greatest risk of mortality, while others such as the palate, 
tongue (at the different sites) or floor of the mouth do not 
appear to influence survival. These results appear to disa-
gree with other studies in which the tongue is the site that 
demonstrates the lowest survival period (20-23). 
It is also important to comment that location in the labial 
commissure could be a variable to take into account in sur-
vival, since the mean life-expectancy is much lower in those 
patients who present a lesion in this site than those that do 
not, however we were obliged to eliminate this factor from 
the definitive model due to the reduced sample size. 
The size of the primary tumor has always been considered 
as a fundamental factor in the majority of tumor prognosis 
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Fig. 1. Overall survival curve.
Fig. 2. Survival curve for the variable: Gender
Fig. 3. Survival curve for the variable: Previous Lesion. 
Fig. 4. Survival curve for the variable: Gingiva.
Fig. 5. Survival curve for the variable: Commissure 





































































































































































































  Ô CI(95%) Ô CI(95%) Ô CI(95%) 
Gingiva Yes 1.745 0.861 3.537 1.895 .879 4.086 1.716 .810 3.637 
Commissure Yes 2.486 0.601 10.292 2.2145 .493 9.931 -- -- -- 
Trigone Yes 2.573 1.296 5.109 2.2019 1.046 4.631 2.136 1.029 4.434 
Size T3+T4 2.732 1.506 4.958 1.6657 .824 3.364 1.888 .961 3.707 
Lymph node N2a+N2b 2.326 1.245 4.343 1.5080 .750 3.033 1.595 .799 3.186 
Smoking Yes 1.710 0.925 3.162 1.2469 .448 3.472 -- -- -- 
Alcohol Yes 2.173 0.918 5.140 1.1564 .563 2.375 -- -- -- 
table 1. Results of Cox regression analysis.
Fig. 7. Survival curve for the variable: Size.
Fig. 8. Survival curve for the variable: Lymph node involve-
ment.
Fig. 9. Survival curves for the variable: Smoking.
Fig. 10. Survival curve for the variable: Periodontal disease.
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and staging systems, including the most universal (TMN), 
in which one of its pillars, the status of  regional lymph 
nodes, constitutes a highly representative prognostic fac-
tor (3). Thus, Kalnins et al. (24) affirm that the presence of 
lymphadenopathy reduces survival at five years to 45%. With 
regard to these factors, our results are in agreement, relating 
the higher T and N stages with lower overall survival.
On the other hand, although in our study we find that 
smoking increases the risk of death from oral cancer, this 
is by only a small percentage given the importance attrib-
uted to this factor in the majority of publications (13, 16). 
This variable even loses significance on carrying out the 
multivariate analysis for which reason it was eliminated as 
a prognostic factor in overall survival. However, we are in 
agreement with other authors such as Browman et al. (25) 
who demonstrated that those cancer patients who continue 
smoking during radiotherapy had a lower survival than 
others. Silverman et al. (26) observed a decrease in risk of a 
second oral or oropharyngeal primary cancer among those 
patients who reduced their smoking habit, which would seem 
to confirm that smoking has a greater affect on a previously 
altered mucosa. 
Regarding alcohol consumption, as occurred with smoking, 
on carrying out the multivariate analysis this variable lost 
significance, which would indicate that its effect is influenced 
by other variables. Thus, Bundgaard et al. (27) eliminate al-
cohol as an independent prognostic factor, since the impact 
of alcohol on survival could be related to the close relation-
ship between alcohol consumption and smoking. 
CONCluSIONS 
There are indications that patients with previous lesions 
tend to survive for longer than those without; presenting 
the lesion in the gingiva increases risk of death by 1.72 times 
than when it is not in this site; location of the lesion in the 
trigone increases risk of death by 2.14 times against those 
not in this site; patients with tumor size greater than T3-
T4 had a risk of death 1.89 times higher than those with a 
tumor in lower stages; patients with a tumor at N2a-N2b 
have a risk of death 1.6 times higher than those with a tumor 
at lower stages. 
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